Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level

[1]  H. Scher,et al.  Clinical implications of PTEN loss in prostate cancer , 2018, Nature Reviews Urology.

[2]  R. Kypta,et al.  WNT signalling in prostate cancer , 2017, Nature Reviews Urology.

[3]  Ming Yan,et al.  Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer , 2017, Genes & development.

[4]  B. Trock,et al.  Prostate MRI prior to radical prostatectomy: effects on nerve sparing and pathological margin status , 2017, Research and reports in urology.

[5]  K. Yousefi,et al.  Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients , 2016, Prostate Cancer and Prostatic Diseases.

[6]  Robert J. Gillies,et al.  Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies , 2016, Oncotarget.

[7]  Tobias Franiel,et al.  Assessment of PI-RADS v2 for the Detection of Prostate Cancer. , 2016, European journal of radiology.

[8]  Jeong Yeon Cho,et al.  PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer , 2016, European Radiology.

[9]  M. Cooperberg,et al.  Genomic Predictors of Outcome in Prostate Cancer. , 2015, European urology.

[10]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[11]  Faraz Hach,et al.  Spatial genomic heterogeneity within localized, multifocal prostate cancer , 2015, Nature Genetics.

[12]  M. Rubin,et al.  Molecular alterations in prostate cancer and association with MRI features , 2015, Prostate Cancer and Prostatic Diseases.

[13]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[14]  P. Febbo,et al.  A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. , 2014, European urology.

[15]  Anirban P. Mitra,et al.  Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy , 2013, PloS one.

[16]  Reddanna Pallu,et al.  Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells , 2013, Front. Oncol..

[17]  Stephen R. Piccolo,et al.  A single-sample microarray normalization method to facilitate personalized-medicine workflows. , 2012, Genomics.

[18]  J. Waxman,et al.  Wnt/β-catenin signalling in prostate cancer , 2012, Nature Reviews Urology.

[19]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[20]  Helen E. Lockstone,et al.  Exon array data analysis using Affymetrix power tools and R statistical software , 2011, Briefings Bioinform..

[21]  J. Yager,et al.  Tissue-specific synthesis and oxidative metabolism of estrogens. , 2000, Journal of the National Cancer Institute. Monographs.

[22]  J. Liehr,et al.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations. , 2000, Journal of the National Cancer Institute. Monographs.

[23]  A. Renshaw,et al.  Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .

[24]  B. Trock,et al.  Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men. , 2016, European urology.

[25]  A. de Bruin,et al.  E2F Transcription Factors Control the Roller Coaster Ride of Cell Cycle Gene Expression. , 2016, Methods in molecular biology.

[26]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.